delphi program (Pfizer Inc)
90
Structured Review
Pfizer Inc
delphi program
Delphi Program, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/delphi+program/delphi+panel/pm25364862-46-8-3
Average 90 stars, based on 1 article reviews
Delphi Program, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/delphi+program/delphi+panel/pm25364862-46-8-3
Average 90 stars, based on 1 article reviews
delphi program - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines Article Snippet: The study was funded by an unrestricted research grant from Article Title: Do current pregnancy weight gain guidelines balance risks of adverse maternal and child health in a United States cohort? Article Snippet: Background: The Institute of Medicine pregnancy weight gain guidelines were developed without evidence linking high weight gain to maternal cardiometabolic disease and child obesity.. The upper limit of current recommendations may be too high for the health of the pregnant individual and child.. Objectives: The aim of this study was to identify the range of pregnancy weight gain for pregnancies within a normal body mass index (BMI) range that balances the risks of high and low weight gain by simultaneously considering 10 different health conditions. Article Title: Disciplinary trends in the use of the Delphi method: A bibliometric analysis. Article Snippet: DK consults on the Article Title: Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature. Article Snippet: Introduction: In numerous clinical practice guidelines, emphasis is placed on the need for coordinated care of psoriatic arthritis (PsA) between rheumatologists and the objective was to develop experience-based points to consider facilitating the implementation of multidisciplinary units (Dermatology/ Rheumatology) for the management of patients with PsA.. Methods: A scientific committee of rheumatology and dermatology experts in the management of PsA, and with experience in joint care, discussed the critical aspects of multidisciplinary PsA Units.. The discussion became the basis for a Delphi survey in two rounds submitted to a panel of 24 specialists in rheumatology and dermatology not involved in PsA units. Article Title: Clinical Burden and Healthcare Resource Utilization Associated With Managing Transfusion-dependent β-Thalassemia in England. Article Snippet: Purpose: Patients with transfusion-dependent β-thalassemia (TDT) have reduced levels of β-globin, leading to ineffective erythropoiesis and iron overload.. Patients with TDT depend on regular red blood cell transfusions (RBCTs) and iron chelation therapy for survival and management of diseaseand treatment-related clinical complications.. This study describes the clinical and economic burden in patients with TDT in England. Article Title: The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement. Article Snippet: Manfred Hauben was a full-time employee at Article Title: Clinical Burden and Health Care Resource Utilization Associated With Managing Sickle Cell Disease With Recurrent Vaso-occlusive Crises in England. Article Snippet: Purpose: Sickle cell disease (SCD) is an inherited red blood cell disease caused by a mutation in the gene encoding the β-subunit of adult hemoglobin that leads to hemolysis, anemia, vaso-occlusive crises (VOCs), morbidity, and mortality.. This study provides a real-world assessment of the clinical burden and health care resource utilization (HCRU) associated with SCD with recurrent VOCs in England.. Methods: This retrospective study linked primary care records from the Clinical Practice Research Datalink database with secondary care records from the Hospital Episode Statistics database to identify patients with SCD with recurrent VOCs between July 1, 2008, and June 30, 2018. Software:Article Title: In silico prediction of pharmaceutical degradation pathways: a benchmarking study. Article Snippet: Zeneth is a new software application capable of predicting degradation products derived from small molecule active pharmaceutical ingredients.. This study was aimed at understanding the current status of Zeneth’s predictive capabilities and assessing gaps in predictivity.. Using data from 27 small molecule drug substances from five pharmaceutical companies, the evolution of Zeneth predictions through knowledge base development since 2009 was evaluated. Functional Assay:Article Title: In silico prediction of pharmaceutical degradation pathways: a benchmarking study. Article Snippet: Zeneth is a new software application capable of predicting degradation products derived from small molecule active pharmaceutical ingredients.. This study was aimed at understanding the current status of Zeneth’s predictive capabilities and assessing gaps in predictivity.. Using data from 27 small molecule drug substances from five pharmaceutical companies, the evolution of Zeneth predictions through knowledge base development since 2009 was evaluated. |